Your search returned 2 results.

Results
	1.	Clinical phase II study of pegylated liposomal doxorubicin as second-line treatment in disseminated melanoma. [electronic resource] by Fink, W Zimpfer-Rechner, C Thoelke, A Figl, R Kaatz, M Ugurel, S Schadendorf, D Producer: 20050215 In: Onkologie vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG. [electronic resource] by Schadendorf, D Ugurel, S Schuler-Thurner, B Nestle, F O Enk, A Bröcker, E-B Grabbe, S Rittgen, W Edler, L Sucker, A Zimpfer-Rechner, C Berger, T Kamarashev, J Burg, G Jonuleit, H Tüttenberg, A Becker, J C Keikavoussi, P Kämpgen, E Schuler, G Producer: 20060927 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search